Literature DB >> 11246078

Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2.

S B Patten1.   

Abstract

BACKGROUND: Cross-sectional studies have reported that certain long-term medical conditions are associated with major depression. Here, these associations are explored using a longitudinal analysis.
METHODS: Data from the first (1994/95) and second (1996/97) waves of the Canadian National Population Health Survey (NPHS) were utilized. The first wave of the NPHS utilized a probability sample of 17626 members of the Canadian population. Members of this cohort were recontacted by Statistics Canada 2 years later. The Composite International Diagnostic Interview Short Form for Major Depression was used to identify episodes of major depression in both waves of the survey. Subjects free of major depression in the year preceding the 1994/95 survey were selected for inclusion in this analysis. The incidence of new-onset episodes in subjects with and without reported long-term medical conditions was compared.
RESULTS: Individuals suffering from one or more long-term medical conditions were found to be at increased risk of major depression. Migraine headaches, sinusitis and back problems were the conditions most strongly associated with major depression. Having a long-term medical condition approximately doubled the risk of major depression in this analysis. LIMITATIONS: The most important limitation of this study was its reliance on self report data about medical conditions.
CONCLUSIONS: A large proportion of the general population in Canada suffers from long-term medical conditions. These individuals are at increased risk of major depression. This study suggests an important role for long-term medical conditions in the etiology of major depression.

Entities:  

Mesh:

Year:  2001        PMID: 11246078     DOI: 10.1016/s0165-0327(00)00186-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  59 in total

1.  [Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].

Authors:  C Ahrens; M Schiltenwolf; H Wang
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

Review 2.  The association of depression with adherence to antihypertensive medications: a systematic review.

Authors:  Chete M Eze-Nliam; Brett D Thombs; Bruno B Lima; Cheri G Smith; Roy C Ziegelstein
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

3.  The health of Canadians on welfare.

Authors:  Nicholas T Vozoris; Valerie S Tarasuk
Journal:  Can J Public Health       Date:  2004 Mar-Apr

4.  Longstanding disease, disability or infirmity and depression in primary care.

Authors:  Janez Rifel; Igor Svab; Danica Rotar Pavlič; Michael King; Irwin Nazareth
Journal:  Wien Klin Wochenschr       Date:  2010-10-01       Impact factor: 1.704

Review 5.  Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

6.  The diagnosis of depression and its treatment in Canadian primary care practices: an epidemiological study.

Authors:  Sabrina T Wong; Donna Manca; David Barber; Rachael Morkem; Shahriar Khan; Jyoti Kotecha; Tyler Williamson; Richard Birtwhistle; Scott Patten
Journal:  CMAJ Open       Date:  2014-10-01

7.  Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Marcus Schiltenwolf
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

8.  The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care.

Authors:  E Asselmann; J Venz; L Pieper; H-U Wittchen; D Pittrow; K Beesdo-Baum
Journal:  Epidemiol Psychiatr Sci       Date:  2017-11-09       Impact factor: 6.892

9.  Functional disability as an explanation of the associations between chronic physical conditions and 12-month major depressive episode.

Authors:  Mariken E Stegmann; Johan Ormel; Ron de Graaf; Josep-Maria Haro; Giovanni de Girolamo; Koen Demyttenaere; Vivianne Kovess; Herbert Matschinger; Gemma Vilagut; Jordi Alonso; Huibert Burger
Journal:  J Affect Disord       Date:  2009-11-24       Impact factor: 4.839

10.  Blockade of protein phosphatase 2B activity in the amygdala increases anxiety- and depression-like behaviors in mice.

Authors:  Amine Bahi; Yann S Mineur; Marina R Picciotto
Journal:  Biol Psychiatry       Date:  2009-08-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.